We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...
AbbVie Inc. closed 5.34% below its 52-week high of $207.32, which the company reached on October 31st.
24/7 Wall St. on MSN6d
AbbVie Just Paid Investors: Here's How Much They ReceivedAbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 ...
5don MSN
In 2024, combined Skyrizi and Rinvoq sales reached $17.7 billion, up 51% year over year, reflecting accelerating global ...
We recently compiled a list of the Top 10 Stocks to Buy According to Lee Munder Capital Group. In this article, we are going ...
GlobalData on MSN7d
AbbVie and Xilio to collaborate on antibody-based immunotherapiesAbbVie has entered a partnership and option-to-license agreement with Xilio for tumour-activated, antibody-based ...
Robert Michael will replace former CEO Richard Gonzalez, marking the official end to Gonzalez’s long reign at the pharma ...
AbbVie Inc. offers a combination of rock-solid business mix, aggressive growth strategy, and shareholder-friendly capital allocation. The company holds strong positions in rapidly growing markets ...
In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV ... employee-owned investment management company. Established in 2000 as Lee Munder Capital Group, it has 25 years ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback